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Molecular mechanisms of protein allostery are not well understood, 
particularly in those systems that undergo disorder to order transitions upon 
activation. BirA is a model allosteric protein in which corepressor, bio-5’-AMP, 
binding enhances dimerization by -4 kcal/mol and is coupled to disordered loop 
folding on both functional surfaces. BirA variants with single alanine substitutions in 
dimerization surface residues are investigated to further characterize communication 
between the two sites. Isothermal titration calorimetry measurements of corepressor 
binding of these BirA variants indicate only the G142A substitution perturbs the free 
energy of binding. The G142A crystal structure indicates a mechanism of 
communication from the corepressor binding to the dimerization surface involving α-
helical extension of residues 143-146. Measurements of heat capacity changes 
associated with corepressor binding to the BirA variants support a model in which the 
 
 
helical extension enhances dimerization by enabling the formation of a network of 
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Chapter 1 : Introduction  
Allostery in Protein Regulation 
Allostery is defined as the functional regulation of one site on a protein by an 
effector at a second site. This effector could be any small ligand, macromolecule, or 
post-translational modification1,2. Biologically, allostery allows modulation of protein 
function based on environmental conditions and is therefore critical for regulation of 
numerous cellular processes including metabolism3, transcription4, and signal 
transduction5. 
Historically, the MWC6 and KNF7 allosteric models were developed to 
describe enzyme cooperativity. These models describe homotropic cooperativity 
using a 2-state, conformational change from a tense, T, to a relaxed, R, state. 
However, the molecular details of these T and R states could only be described when 
crystal structures, such as those first obtained for horse hemoglobin were obtained by 
Max Perutz in 19708. With this data, he was able to develop a structural model for the 
T to R transition in hemoglobin. These structures allowed development of a 
molecular mechanism of the allosteric transition communication in hemoglobin in 
which O2 binding induces the breakage of constraining inter-subunit salt bridges. 
When these intermolecular salt bridges are removed, the free energy of subsequent O2 
binding steps is more favorable leading to positive homotropic cooperativity.  
Allosteric mechanisms for proteins have now been characterized for a number 
of other systems. For example, Datta et. al. observed a pathway of 21 hydrogen bonds 




caspase-1 dimer. Only 12 of these hydrogen bonds were present in the apo protein9. 
Alanine mutagenesis significantly alters protease activity for four residues spanning 
the distance between the two sites indicating an apparent allosteric pathway. 
However, the secondary structure of proteins is not necessarily well defined. 
Both partially disordered proteins and intrinsically disorder proteins (IDPs) that have 
no well-defined secondary structure have been characterized10,11. Biologically, protein 
disorder is thought to allow for multispecificity in protein-protein interactions and is 
widely observed in signaling and regulatory pathways12,13. The folding of disordered 
regions upon effector binding allows the formation of additional intramolecular 
interactions associated with allosteric regulation. However, disorder to order 
transitions and their mechanistic roles in protein allostery are not well understood. 
Above 30% of all protein residues in eukaryotes are predicted to contain disordered 
regions14 and this knowledge gap could prove to be a significant barrier to protein 
structure-function prediction and drug design. Within this thesis the allosteric 
mechanism in one model protein, BirA, for which disordered loop folding is coupled 
to its allosteric activation is investigated.  
BirA as a model allosteric system 
E. coli BirA functions as both a transcriptional repressor and critical enzyme 
for fatty acid biosynthesis (Figure 1.1). Both functions require BirA-catalyzed 
synthesis of its corepressor, bio-5’-AMP, from biotin and ATP. The corepressor 








Figure 1.1: BirA in the E.coli biotin regulatory system.  
Following bio-5’-AMP synthesis, holoBirA dimerizes to form either a catalytic heterodimer 
(left) or a DNA-binding homodimer (right) on the same dimerization surface15. 
 
Figure 1.2: Thermodynamic cycle illustrating coupled bio-5’-AMP binding and 
dimerization. 






kcal/mol17. Following dimerization, BirA binds to the biotin operator, BioO, 
repressing transcription of biotin biosynthetic genes17. Bio-5’-AMP binding and 
subsequent homodimerization are important elements of the regulation of biotin 
biosynthesis in E. coli. Moreover this process serves as a model system for studying 
the mechanistic basis of protein allostery. 
Disordered loops play a role in the BirA allosteric mechanism 
Bio-5’AMP binding occurs at a site which includes two loops that are 
unfolded prior to ligand binding. Residues 116-126, the biotin binding loop (BBL), 
fold when biotin is bound. In addition to the BBL, residues 211-234, the adenylate 
binding loop (ABL), become ordered upon bio-5’-AMP binding (Figure 1.3). 
The ABL is critical for adenylate binding as evidenced by single alanine substitutions 
in this loop, which perturb bio-5’-AMP binding by up to 3.4 kcal/mol18. Upon bio-5’-
AMP binding, a majority of these BirA variants also show decreased protein 
protection from site-specific subtilisin cleavage between residues 217 and 218 in the 
ABL, consistent with perturbation of loop folding18,19. Substitutions in the ABL also 
perturb holoBirA dimerization free energy by 0.5-1.5 kcal/mol, indicating functional 
communication to the dimerization surface. Together, these results are consistent with 
communication from the ligand binding surface to the dimerization surface by 
coupled corepressor binding and ABL folding. 
Similarly, perturbations were made in several dimerization surface loops to 
investigate their role in assembly of the BirA dimer. Alanine substitutions were made 
in four dimerization surface loops comprised of residues 140-143, 170-167, 193-197, 






Figure 1.3: Structural comparison of apo and holoBirA. 
Apo BirA (PDB entry 1BIA) and a monomer of the holoBirA dimer (PDB entry 2EWN) are 
shown with the non-hydrolysable bio-5’-AMP analog, biotinol-5’-AMP (black), bound. 
Following ligand binding and subsequent dimerization, residues 116-124 (red), 212-222 
(blue), and 194-197 (pink), and glycine 142 of the 140-143 (dark green) loops become 
ordered. Residues in the 170-176 (orange) and 280-283 (purple) loops are folded regardless 
of ligand binding. 
 
Figure 1.4: Functional loops in the BirA dimer. 
Due to their presence on the dimerization surface, alanine substitutions in the 140-143 
(green), 194-197, (pink) and 280-283 loops are investigated for their role in allosteric 




(Figure 1.4) and the resulting proteins have variable ΔG°DIM values consistent with 
their roles in BirA dimerization20(Figure 1.5). 
Alanine substitution at residue G142 gives the largest perturbation to the 
dimerization free energy of 4.4±0.6 kcal/mol. In other words, G142A BirA dimerizes 
with energetics similar to those measured for apo BirA. This variant is also perturbed 
in adenylate binding by 3.0±0.4 kcal/mol relative to wild type BirA19. Consistent with 
abolition of coupling between corepressor binding and dimerization, the monomeric 
structure G142A BirA bound to biotinol-adenylate, a non-hydrolyzable bio-5’-AMP 
analog, resembles that of wild type apo BirA. Additionally residues 193-199 on the 
dimerization surface and residues 211-221 in the ABL are disordered in the G142A 
structure. This provides evidence for the role of coupled disorder-to-order transitions 
on the two functional surfaces in allosteric activation of the BirA monomer19. 
The data obtained for G142A BirA was the first to functionally demonstrate 
communication from the dimerization surface to the ligand binding surface. However, 
it is not known if other residues on the dimerization surface also communicate to the 
ligand binding surface. This paper further investigates the mechanism of 
communication from the dimerization to the ligand binding surface in the BirA 
monomer. By measuring corepressor binding of other alanine-substituted variants in 
the dimerization surface loops using isothermal titration calorimetry (ITC) titrations, 
both Gibbs free energy and enthalpy of bio-5’-AMP binding are determined. From 
these parameters, the entropy change of corepressor binding can be calculated so that 
the thermodynamic contributions to ligand binding can be discussed. Similar to 




indicate other residues that also functionally communicate to the ligand binding 
surface.  
To further characterize the source of alterations in corepressor binding, the 
heat capacity change of bio-5’-AMP association was determined by linear regression 
of the temperature dependence of the binding enthalpy. Binding enthalpies from 10 to 
25°C were measured using ITC at total association at partial saturation (TAPS) 
conditions21. The heat capacity change of bio-5’-AMP binding is negative for all 
variants and significant deviations from that of wild type BirA are observed. 
Following a correction for the contribution of BirA dimerization, a strong correlation 
between heat capacity change and the free energy of dimerization is observed for 
most variants. Residues for which the heat capacity change is more positive are those 








Figure 1.5: BirA∙bio-5’-AMP homodimerization free energies of dimerization surface 
variants. 
Homodimerization free energies of bio-5’-AMP bound wild type (white) and single alanine 
variants in the 140-143 (green), 170-176 (orange), 193-197 (pink), and the 280-283 (purple) 
dimerization surface loops. Error bars represent the standard deviation from at least two 
sedimentation equilibrium measurements in 10mM Tris (pH 7.50), 200mM KCl, and 2.5mM 




Chapter 2 : Materials and Methods 
Chemicals and biochemicals 
All chemicals and biochemicals used in this study were at least reagent grade. 
Isopropyl-β-D-1-thiogalactopyranoside (IPTG) was purchased from Teknova and 1M 
solutions were prepared in MQH20 (Millipore—Milli-Q synthesis, 
resistance=18.2MΩ∙cm) from dry powder immediately prior to use. A 100mM 
phenylmethylsulfonyl fluoride (PMSF, Sigma) solution was prepared by dissolving 
the dry powder in 95% ethanol. Luria Bertani (LB) broth for bacterial growth was 
prepared using 10g/L tryptone (Bacto), 5g/L yeast extract (Bacto), 5g/L NaCl 
(Mallinckrodt), 0.1% 1M NaOH (Fisher), and was used less than a week after 
sterilization by autoclaving at 250°F, 22 psi, for 20 minutes. Ampicillin (AMP, 
Fisher) was prepared as a fresh 100mg/mL solution in MQH2O immediately before 
addition to liquid LB media or LB-agar. Polyethylenimine (PEI) was purchased from 
Sigma and diluted to a 10% working solution in MQH20. This solution was adjusted 
to a pH of 7.5 with HCl. 
Because biotin has no spectral signal, it must be quantitatively prepared so 
that the concentration can be accurately known. D-biotin was obtained from Sigma-
Aldrich and prepared in Standard Buffer (10mM Tris pH 7.5 at 20°C, 2.5mM MgCl2, 
200mM KCl). Due to its poor solubility in H20, (0.22mg/mL, or 900μM at 25°C
22), 
care was taken to prepare biotin solutions at a concentration well below this value. 
This ensures the weight of biotin measured accurately represents dissolved biotin and 




into a small beaker, in which the stock solutions for 25mL of Standard Buffer (1M 
Tris Base, 1M MgCl2, 2M KCl) were added. After the addition of 80% of the total 
volume as MQH20 to dissolve the lyophilized powder, the pH of the solution was 
adjusted to 7.50 at 20°C with HCl. Following quantitative transfer to a 25mL 
volumetric flask, the remaining volume of MQH2O was added to bring the final 
volume to 25mL. The biotin solution was subsequently filtered with a 0.22µm mixed-
cellulose GSWP filter (Millipore) that was pre-rinsed with MQH20. Following the 
filtration, the solution was aliquoted into 1mL fractions and stored at -80°C to 
minimize oxidation.  
The bio-5’-AMP was synthesized and purified in lab as previously 
described23,24. As an anhydride, hydrolysis of bio-5’-AMP to its constituents, biotin 
and adenosine monophosphate (AMP), can occur. Adenylate integrity was assessed 
by chromatographic separation on a cellulose F, TLC membrane (EMD) using a 
mobile phase of 3:2:1 (v:v:v) of amyl alcohol, formic acid, H20 respectively. Greater 
than 1nmol of biotin or bio-5’-AMP was visualized with a stain comprised of 1% 
H2SO4, 0.1% p-dimethylcinnemaldehyde solution in 95% ethanol. This solution 
quickly stains biotin-containing compounds bright pink. Purity was assessed by the 
presence of only a single bio-5’-AMP band (Rf=0.53).  
Expression and purification of BirA variants occurred as previously 
published20 except for wild type, E140A, and K283A BirA. These proteins were 





Isothermal titration calorimetry (ITC) measurements 
All titrations were performed on a Microcal VP-ITC (Malvern) calorimeter 
with a 1.44mL cell volume. For all experiments, the sample cell contained protein and 
the 250μL mixing syringe contained the ligand. In each titration, 21-23 injections of 
ligand were added into the sample cell. Titrations were designed with two factors in 
mind: first the c-value ( 𝑐 = 𝐾𝐴𝑃𝑡𝑛; where KA is the association constant, Pt is the 
total protein concentration, and n is the stoichiometry of ligand binding), for the 
binding curve was within the recommended range for association constant 
determination of 5-500 (500 ≥
𝑃𝑡∙𝑛
𝐾𝐷
≥ 5)28. Second, care was taken so that both pre-
saturation and post-saturation enthalpy plateaus were represented by several 
injections. This required the use of a larger number of lower-volume ligand 
injections. These factors, as well as usage of an experimental design tool29 are 
detailed in Appendix 2. 
Prior to performing a titration, all protein solutions (200-500uL) were 
dialyzed twice, the second dialysis overnight, in 250mL of 0.22um-filtered (GSWP) 
Standard Buffer (10mM Tris pH 7.5 at 20°C, 2.5mM MgCl2, 200mM KCl) at 4°C. To 
eliminate any precipitate, the protein solution was then filtered with a 0.45um PTFE 
syringe filter. The concentration of the protein solution was determined using 
absorbance spectroscopy (εM, 280nm=47510M-1cm-1). During this process the buffer 
from dialysis was degassed for at least 8 min using the Microcal ThermoVac 
accessory. To ensure buffer matching, this dialysate was used to dilute both protein 
and ligand solutions to the appropriate final concentrations (see results). Directly 




the Microcal ThermoVac accessory 2-3°C above the working temperature. To further 
prevent interference from bubble formation/popping during the titration, each 
experiment was initiated with a 2μL injection to clear the syringe tip. The default stir 
speed and data filter time of 310 rpm and 2 seconds respectively were used for all 
titrations. Both the ‘Fast Equilibration’ and ‘Auto Equilibration’ options were used 
with the ‘High’ gain/feedback setting.  
Integration of the raw titration peaks was performed in the Microcal software 
suite in Origin 7.0; this process consisted of first computer-assisted baseline 
assignment followed by manual refinement. Multiple analyses of identical titration 
data indicated little variation in binding parameters. The heat of injection was 
assumed to be constant for all titrations based on previous biotin and bio-5’-AMP 
dilution experiments. This heat was calculated from the average value of heats 
associated with the final 4-5 injections of the titration, which were after protein 
saturation. Prior to model-fitting, this heat was subtracted from each heat of injection 
to obtain the heat of ligand binding. Injection heats were normalized to the moles of 
ligand injected, resulting in the final molar heats of injection. Each isotherm was fit 
using nonlinear least squares regression to a binding model in Origin 7.0 (see Direct, 
Displacement, and TAPS titrations below). It was from this regression that the 
equilibrium constant, molar enthalpy, and stoichiometry of binding was determined.  
The sample cell contents were removed following each titration, after which 
the cell was thoroughly washed with 800mL of working concentration of RBS35 
detergent (1:50 RBS35:diH20) using the Microcal ThermoVac. To remove this 




use, the sample cell was filled with MQH2O to prevent both the need for later 
equilibration in water and the deposition of any residue by evaporation of the cell 
contents. 
Direct ITC binding measurements of biotin binding parameters 
The direct binding method was used to determine the binding parameters for 
the BirA dimerization surface variants to biotin and for BirA variant G142A to bio-5-
AMP. The design of direct binding titrations was aided by a spreadsheet-based 
simulation tool for a single-site binding model29. Each biotin titration consisted of 
twenty-one 7μL injections of 50 µM biotin into a 2.5μM BirA solution and was 
terminated by a single 100μL injection. This final injection sufficiently saturated 
BirA with biotin for a following displacement titration (see Displacement ITC). The 
Bio-5’-AMP direct titrations were performed with twenty 13μL injections of 20 µM 
bio-5’-AMP into a 2μM BirA solution. For all direct titrations, a 300 second delay 
between injections was sufficient for complete baseline equilibration. Integration of 
the resulting injection peaks yields the molar heat of injection, qi. Following baseline 























using Origin 7.0 least-squares analysis software to determine the association constant, 




Displacement ITC binding measurement of bio-5’-AMP binding 
parameters 
Direct measurement of KA, bio-5’-AMP was not possible for several variants due 
to the corepressor’s tight interaction with BirA (KD, bio-5’-AMP<10
-10M)30. To achieve 
an adequate c-value for KD,bio-5’-AMP  measurement, a nanomolar protein concentration 
would be required. However, this protein concentration would provide an insufficient 
heat of binding to distinguish itself from the heat of dilution. Instead, bio-5’-AMP 
displacement of biotin from saturated BirA was measured. With this method, the 
apparent association constant, KA, app, is within an accessible range. This value is a 
function of the KA, Biotin (see direct binding) and KA, bio-5’-AMP, as well as the bulk 





Similarly, the enthalpy of bio-5’-AMP binding can be deconvoluted from the 
apparent measured binding enthalpy using the following expression in which ΔH°biotin 
has been previously measured by a direct titration. 




However, binding enthalpies determined by this method were not used in analysis of 
the titration data (see appendix 1). Instead, those values obtained from direct TAPS 
titrations were used.  
Displacement titrations were designed so that upon injection, bio-5’-AMP 
displaces biotin at its shared binding site on BirA. To ensure complete biotin 




Biotinx100), which was achieved at the end of each direct titration. To perform each 
displacement titration, twenty-one 12μL injections of 22μM bio-5’-AMP and 6µM 
biotin were titrated into the sample cell, containing 2.2µM BirA and 6µM biotin. Due 
to the slower kinetics of the displacement reaction, a longer, 360 second, equilibration 
period was required between injections.  
Total association at partial saturation (TAPS) calorimetry 
Calorimetric titrations in TAPS conditions21 were utilized to measure ∆Hbio-5’-
AMP at temperatures ranging from 10°C-25°C for the purpose of calculating the molar 
heat capacity of corepressor binding. This method allows for more accurate 
determination of the binding enthalpy by decoupling it from the equilibrium 




at which there is complete binding upon ligand injection, for multiple injections. 
Because of the large dependence of pKatris on temperature, the pH of standard buffer 
used was adjusted using HCl to pH=7.5 at each working temperature. The faster 
kinetics of direct binding permitted a 300 second delay between injections. For all 
TAPS titrations, five 7μL injections of 20μM bio-5’-AMP are followed by a single, 
saturating, 180μL injection and terminated by six 10μL injections. The integrated heat 
from the first five injections represents the sum of the heat of binding and heat of 
dilution, ∆𝐻°𝑡𝑜𝑡. 
∆𝐻°𝑡𝑜𝑡 = ∆𝐻°𝑏𝑖𝑜−5′−𝐴𝑀𝑃 + ∆𝐻°𝑑𝑖𝑙 
The final six injections represent the molar heat of dilution,  ∆𝐻𝑑𝑖𝑙. The difference of 




∆𝐻°𝑏𝑖𝑜−5′−𝐴𝑀𝑃 = ∆𝐻°𝑡𝑜𝑡 − ∆𝐻°𝑑𝑖𝑙 
By subtraction of the average experimental heat of dilution, five measurements of the 
molar enthalpy, corresponding to the five pre-saturation injections, were obtained at 
each temperature. 
Molar heat capacity changes of bio-5’-AMP binding 
Heat capacity changes of bio-5’-AMP binding by the BirA variants were 
calculated using the ∆𝐻bio-5’-AMP values from the ITC-TAPS titrations above. The heat 
capacity change, ΔC°P, is the slope of the linear enthalpy versus temperature 
relationship, ∆𝐻° = 𝑞𝑃 = ∆𝐶𝑃° ∙ ∆𝑇 , as determined by linear regression. Each 
calculation of ∆C°p was comprised of five enthalpies of bio-5’-AMP binding at each 




Chapter 3 : Results  
Allosteric activation of BirA for dimerization occurs via communication of 
disorder-to-order transitions at the corepressor binding and dimerization surfaces. 
This was communication was further investigated by measuring the ligand binding 
properties of dimerization surface variants using isothermal titration calorimetry 
(ITC). 
Selection of alanine-substituted dimerization surface variants  
BirA variants with alanine substitutions in four dimerization surface loops 
reveal a range of effects (Figure 1.5) on the equilibrium dimerization constant20. A 
subset of these variants was selected for ligand binding measurements based on the 
following criteria: 
Variants in the 170-176 dimerization loop were not studied due to their 
proximity to the active site and known role in catalysis20. In the remaining three 
loops, only variants with dimerization affinities similar to or lower than that measured 
for wild type BirA were studied. This approach was adopted to target variants that, 
like G142A BirA, are more likely to be defective in communication to the ligand 
binding surface. Moreover, weak dimerization also minimizes contributions from the 
41±3 kcal/mol homodimerization enthalpy to the ITC measurements31. Using these 
criteria, variants  E140A, G142A, P143A, T195A, G196A, D197A, I280A, G281A, 
and K283A were selected. The dimerization energetics of these variants are 












Table 3.1: Homodimerization energetics of chosen BirA variants: 
Errors represent the standard deviation from at least two sedimentation equilibrium 
measurements in 10mM Tris (pH 7.50), 200mM KCl, and 2.5mM MgCl2 at 20°C.20 
 









































Dimerization loop variants bind biotin with affinities similar to wild 
type BirA 
As a control for the presence of non-allosteric effects on ligand binding, such 
as loss of binding site integrity, biotin binding to all variants was measured. Since this 
ligand does not elicit an allosteric response16, perturbations to biotin binding are 
unlikely to reflect effects on inter-surface communication. Thermodynamic 
parameters of biotin binding were obtained by direct ITC binding titrations. See 
materials and methods for experimental details.  
ITC titration data for biotin binding to I280A BirA are shown in Figure 3.1. 
Analysis of the data indicated excellent agreement to a single site binding model, 
yielding the dissociation constant, molar enthalpy, and stoichiometry of biotin 
binding from which the Gibbs free energy, ∆G°biotin, and entropy, -T∆S°biotin were 
calculated. The values of these parameters for the I280A variant (Table 3.2) are 
identical, within one standard deviation, to those obtained for wild type BirA.  
Biotin binding titrations performed on all other variants yielded data that are 
also well described by a single site model. Moreover, the thermodynamic parameters 
obtained from analysis of the titration data are, with few exceptions, equivalent to 
those obtained for wild type BirA (Table 3.2). For all variants, the equilibrium 
dissociation and Gibbs free energy of binding are identical and the same as those 
obtained for wt BirA. However, the thermodynamic contributions to the free energy 
of binding for G142A BirA differ from those obtained for wild type BirA. The molar 







Figure 3.1: Direct biotin titration of I280A BirA.  
This figure illustrates data for the direct binding ITC method. Each titration was performed 
by injecting twenty 7uL injections of 50 µM biotin into 1.44mL of BirA. Both protein and 
ligand solutions were prepared in 10mM Tris (pH=7.50 at 20°C), 200mM KCl, and 2.5mM 
MgCl2. The top panel is the ITC data trace following manual baseline correction. After 
integration and normalization to the moles of injectant, the binding isotherm, bottom panel, 







Table 3.2: Thermodynamic parameters of biotin binding for BirA variants 
 
 
Measured at 20°C by direct ITC titration in 10mM Tris (pH=7.50 at 20°C), 200mM KCl, 
2.5mM MgCl2. Each parameter represents the average from at least two independent 
measurements. The uncertainty provided is the propagated 68% confidence interval from 
the nonlinear-least-squares regression to a single site model.  
 
Figure 3.2: Comparison of thermodynamic parameters of biotin binding for BirA variants. 
 A) Change in the Gibbs free energy of biotin binding, ∆∆G°biotin, variant - ∆∆G°biotin, wt, shown for 
the nine variants. Error bars shown represent propagated 68% confidence intervals from 
wild type and the appropriate variant. B) The enthalpic (red) and entropic (blue) 
components of the biotin binding free energy for each BirA variant at 20oC. Errors bars 














 -9.8±0.1 -20.1±0.4 10.3±0.5 0.93±0.01 
E140A 4.0(±0.4)x10
-8
 -9.92±0.05 -20.1±0.2 10.2±0.2 0.931±0.006 
G142A 4.0(±0.4)x10
-8
 -9.92±0.06 -21.9±0.2 12.0±0.3 1.085±0.009 
P143A 4.5(±0.3)x10
-8
 -9.85±0.04 -19.7±0.1 9.9±0.1 0.955±0.004 
T195A 4.5(±0.5)x10
-8
 -9.85±0.06 -19.9±0.2 10.1±0.2 0.894±0.007 
G196A 5.1(±0.5)x10
-8
 -9.78±0.06 -20.3±0.2 10.5±0.2 0.984±0.007 
D197A 4.2(±0.4)x10
-8
 -9.89±0.05 -20.1±0.2 10.2±0.5 1.260±0.008 
I280A 4.6(±0.5)x10
-8
 -9.84±0.06 -20.6±0.2 10.8±0.2 1.027±0.007 
G281A 4.1(±0.4)x10
-8
 -9.91±0.05 -20.4±0.2 10.5±0.2 0.878±0.006 
K283A 3.9(±0.2)x10
-8





BirA. Additionally, the entropic component of binding, -T∆S°biotin, is 1.7±0.6 
kcal/mol less favorable. Nonetheless, the free energy of biotin binding remains 
equivalent to that of wild type at -9.92±0.06 kcal/mol. 
With one exception, the resolved stoichiometries of biotin binding range from 
0.878 and 1.085 are consistent with a 1:1 binding stoichiometry. The exception, BirA 
D197A, yields a reproducibly higher value of 1.260±0.008. Since this value is 
consistent with results of stoichiometric titrations monitored by fluorescence, 
(unpublished data) this behavior appears to be an intrinsic property of the variant. 
Alanine substitution at residue G142 greatly perturbs bio-5’-AMP 
binding. 
The perturbed ABL folding of the G142A BirA variant indicates functional 
communication from the BirA dimerization surface to the ligand binding surface32. 
The alanine-substituted variants that are also defective in dimerization were analyzed 
to determine if this communication, measured by loss of bio-5’-AMP binding affinity, 
extends to other residues on the dimerization surface. 
Because of the high c-values that would be required, the affinity             
(KD,bio-5’-AMP = 5(±2)x10
-11M) of bio-5’-AMP to wild type BirA precludes the use of 
direct binding ITC titrations. Therefore, it was necessary to perform corepressor 
binding measurements using the displacement titration method33. 
For this experiment, biotin-saturated BirA is titrated with bio-5’-AMP which 
displaces biotin in the course of binding. Nonlinear least squares analysis of this 
isotherm using a single site model yields the apparent binding parameters used to 




 Data obtained for the I280A BirA displacement titration are shown in Figure 
3.3. In contrast to biotin binding, this titration is endothermic in its initial injections. 
This is because the positive enthalpy of biotin release is larger in magnitude than the 
negative enthalpy of bio-5’-AMP binding. Consequently, the apparent molar binding 
enthalpy for these measurements was about +6kcal/mol, compared to -20 kcal/mol for 
the direct biotin binding titrations. This results in a lower signal-to-noise for the 
parameters obtained using the competitive binding method. Nonetheless, the data are 
well described by the single site model. Moreover, the thermodynamic parameters of 
bio-5’-AMP binding (Table 3.3) derived from the analysis indicate that I280A BirA 
is characterized by corepressor binding parameters identical to those determined for 
wild type BirA.  
Displacement titrations were used to measure bio-5’-AMP binding to all 
variants with the exception of G142A BirA. These measurements yielded free 
energies of bio-5’-AMP binding (Figure 3.4A) identical, within one standard 
deviation, to that of wild type BirA. The direct titration of G142A BirA with the 
corepressor indicated much weaker binding with an equilibrium dissociation constant 
of 8(±1) x10-9 M, approximately 160-fold greater than that measured for wt BirA. 
The enthalpies of ligand binding obtained by displacement titration were 
deemed innacurate (see appendix1) and therefore are excluded from these results.The 
enthalpies derived from TAPS titrations give insight into the effects observed in the 
variants. In contrast to the Gibbs free energies of binding, the BirA variants display 
variable enthalpic and entropic components to bio-5’-AMP binding, illustrated in 





Figure 3.3: Biotin Displacement bio-5’-AMP titration of I280A BirA.  
This figure illustrates data for the competitive binding ITC method. Each titration was 
performed by injecting 20-22, 12uL injections of 22 µM bio-5’-AMP into 1.44mL of BirA. 
Both protein and ligand solutions were prepared in 10mM Tris (pH=7.50 at 20°C), 200mM 
KCl, 2.5mM MgCl2, and 6µM biotin. The top panel is the ITC data trace following manual 
baseline correction. Following integration and normalization to the moles of injectant, the 
binding isotherm, bottom panel, is obtained. The binding isotherm for I280A BirA is fit to a 
single site model for the apparent binding parameters from which the bio-5’-AMP binding 
parameters are calculated 
Table 3.3: Thermodynamic parameters of bio-5’-AMP binding. 
 
Above binding parameters were measured at 20°C by displacement ITC titration in 10mM 
Tris (pH=7.50 at 20°C), 200mM KCl, 2.5mM MgCl2. Each parameter represents the average 
from at least two independent measurements. Uncertainty provided is the propagated 68% 
confidence interval from the nonlinear-least-squares regression to a single site model. 
a Obtained from nonlinear least squares analysis of displacement titration data to a single 
site binding model in Origin 7.0. 
bEnthalpy obtained from direct TAPS titration at 20°C. 
c Entropy, -T∆S°, calculated using the expression ∆G°=∆H°-T∆S°  
 




















 -14.1±0.5 -12.6±0.3 -1.4±0.5 1.06±0.02 
E140A 7(±3)x10
-11
 -13.6±0.2 -12.43±0.06 -1.2±0.2 0.90±0.01 
G142A 8 (±1)x10
-9
 -10.85±0.09 -13.3±0.1 2.9±0.2 1.01±0.01 
P143A 8(±2)x10
-11
 -13.5±0.2 -12.2±0.01 -1.4±0.2 0.96±0.01 
T195A 10(±4)x10
-11
 -13.4±0.2 -12.58±0.07 -0.9±0.2 0.88±0.01 
G196A 2(±3)x10
-11
 -14.2±0.8 -11.90±0.1 -2.4±0.8 1.09±0.03 
D197A 9(±3)x10
-11
 -13.5±0.2 -12.43±0.2 -1.1±0.3 1.21±0.02 
I280A 9(±2)x10
-11
 -13.5±0.1 -12.5±0.1 -0.9±0.2 1.06±0.01 
G281A 8(±3)x10
-11
 -13.6±0.2 -12.7±0.2 -0.9±0.3 0.89±0.01 
K283A 9(±2)x10
-11











Figure 3.4: Energetic contribution to bio-5’-AMP binding for BirA variants. 
A) Change in the Gibbs free energy of bio-5’-AMP binding, ∆∆G°bio-5’-AMP, variant-∆∆G°bio-5’-AMP, wt, 
for the nine variants studied. Error bars are the propagated uncertainties from both wild 
type and appropriate variant. B) The enthalpic (red) and entropic (blue) components of the 
free energy of bio-5’-AMP binding for each BirA species studied. Errors bars shown are the 




wild type reflects both a modestly more favorable ∆H°G142A, by -0.g237±0.3 kcal/mol 
, and less favorable -T∆S°G142A of 4.3±0.5 kcal/mol. In agreement with the biotin 
binding measurements, the stoichiometries of bio-5’-AMP binding, shown in Table 
3.3, are consistently between 0.89 and 1.09, except for variant D197A 
ΔC°p,bio-5’-AMP is more negative for BirA dimerization surface variants 
To further probe the structural basis of the BirA allosteric mechanism, the 
heat capacity changes associated with bio-5’-AMP binding to the variants were 
determined from measurements of the temperature dependence of the enthalpy of 
ligand binding. For each protein, the enthalpy of bio-5’-AMP binding was measured 
between 10°C and 25°C using the ITC total association at partial saturation (TAPS) 
method21. 
TAPS titration data for BirA variant G196A are shown in Figure 3.5. 
Analogous to the direct biotin titration in Figure 3.1, the initial five injections, when 
integrated, represent the combined heats of ligand binding and ligand dilution. A 
large injection of bio-5’-AMP then saturates the protein so that the remaining six 
injections only measure the heat of ligand dilution. The difference in the heats for 
these injections, when normalized to the ligand concentration, yields the molar 
enthalpy of binding. Therefore, from a single titration, five measurements of the bio-
5’-AMP binding enthalpy were obtained.  
Linear regression of this data for G196A BirA yields a heat capacity change 
associated with bio-5’-AMP binding of -240±6 cal/mol∙K. The r2 value of the linear 
regression, 0.95, indicates the heat capacity change was constant over the temperature 




Linear regression of the molar bio-5’-AMP binding enthalpy versus 
temperature data for the remaining BirA variants (Table 3.4) indicated a constant 
heat capacity over the temperature range employed as judged by r2 values ranging 
from 0.91 to 0.98. The ∆C°p,bio-5’-AMP is more negative for all variants than the value 
obtained for wild type. The ∆C°p, bio-5’-AMP values are, within one standard deviation, 
identical within the 280-283 loop. Additionally, no significant differences in ∆C°p, bio-
5’-AMP are observed among variants E140, P143A, T195A and D196A. The tightest 
dimerizing variant, G196A BirA, has the most positive heat capacity but, G142A 












Figure 3.5: Bio-5’-AMP TAPS titration of G196A BirA 
Each titration was performed by injecting first five, 7µL injections of 20 µM bio-5’-AMP into 
1.44mL of BirA. To saturate the protein solution, 180µL of 20µM bio-5’-AMP were injected. 
After saturation, six 10µL injections of 20 µM bio-5’-AMP were performed. Both protein and 
ligand solutions were prepared in 10mM Tris (pH=7.50 at 20°C), 200mM KCl, 2.5mM MgCl2. 
The top panel is the ITC data trace following manual baseline correction. After integration 
and normalization to the moles of injectant, the binding isotherm, bottom panel, is 
obtained. The difference between the molar heat before and after protein saturation 














Figure 3.6: Heat capacity change of bio-5’-AMP binding for G196A BirA.  
The heat capacity change was obtained from the slope of linear least squares regression of 
the enthalpy-temperature relationship, ∆𝐶𝑝° =
∆𝐻°
∆𝑇°
 . Either four or five measurements of 
∆H°bio-5’-AMP were obtained at each temperature by a single ITC-TAPS titration at 10, 15, 20, 




Table 3.4: Heat capacity change of bio-5’-AMP binding for BirA dimerization surface 
variants. 
 
Calculated from linear regression of the temperature dependence of ∆H°bio-5‘-AMP (Figure 3.6). 
Uncertainty given in ∆C°p is the 68% confidence interval from linear regression. Change in 
∆C°p from wild type, ∆∆C°p, is calculated by ∆C°p,variant-∆C°p,wt. Uncertainty in ∆∆C°p is the 






















































Figure 3.7: Comparison of heat capacity change measurements. 
The ∆C°p of wild type (grey), upon alanine substitution in the 140-143 loop (green), the 193-
197 loop (pink) and the 280-283 loop (purple). Error bars are the standard deviation of the 











wild type -0.30±0.01 — 
E140A -0.37±0.03 -0.07±0.01 
G142A -0.300±0.008 -0.00±0.03 
P143A -0.363±0.008 -0.06±0.01 
T195A -0.37±0.01 -0.07±0.01 
G196A -0.240±0.006 0.06±0.01 
D197A -0.364±0.009 -0.06±0.01 
I280A -0.31±0.01 -0.01±0.01 
G281A -0.31±0.01 -0.01±0.01 




Chapter 4 : Discussion 
The loss of Gibbs free energy of both dimerization and bio-5’-AMP binding 
measurements in G142A BirA indicate that coupling between ligand binding and 
dimerization has been abolished. Of the alanine substitutions introduced on the 
dimerization surface, only G142A results in defective bio-5’-AMP binding indicating 
disruption of elements critical for site-to-site communication in the wild type protein. 
Consistent with the role of disorder-to-order transitions in allosteric activation of the 
BirA monomer, the G142A crystal structure indicates an unfolded ABL and 193-197 
loop. Additionally, N-terminal extension of the 147-164 helix by four residues that is 
observed in wild type BirA upon corepressor binding is not observed in the G142A 
structure. 
Large heat capacity changes upon bio-5’-AMP binding for the variants 
indicate that although communication to the ligand binding surface is not observed 
for the remaining residues, perturbations to the dimerization surface are present and 
correlate well with the resulting effects on BirA dimerization free energy. Moreover, 
these results are consistent with formation of intramolecular interactions upon loop 
folding being critical for the modulation of dimerization free energy. 
BirA integrity is maintained upon alanine substitution 
Alanine substitutions in all dimerization surface variants elicit no observable 
penalty to the free energy of biotin binding. Therefore, it is reasonable to assume that 
there is no large conformational change or loss of protein stability resulting from 




further supported by the BirA G142A crystal structure which demonstrates retention 
of secondary structural elements present in apo BirA and the holo BirA monomer. 
Moreover, alanine substitutions in the ABL induced deficient bio-5’-AMP binding 
without disturbing the free energy of biotin binding18. Therefore, because alanine 
substitutions in these flexible loops do not indicate disruption of the protein structure, 
any alteration to the Gibbs free energy of bio-5’-AMP binding upon alanine 
substitution can be considered due to perturbation of long distance allosteric 
communication. 
Residue G142 displays evidence for communication to the ligand 
binding site  
The free energy of bio-5’-AMP binding is only perturbed by alanine 
substitution at residue G142. As discussed above, this result demonstrates 
perturbation of a long distance communication from the dimerization loop residues to 
the ligand binding surface. Therefore, the structural differences observed in G142A 
BirA represent perturbations to the features of the allosteric activation of BirA 
(Figure 4.1). The 193-197 loop remains folded in the G142A structure and alanine 
substitutions in this region do not perturb ligand binding. Therefore the folding of 
residues 193-197 is not a direct consequence of ABL folding. Instead, it must be 
influenced by other local effects, such as intramolecular interactions that form as a 
consequence of the 143-146 alpha helical extension. However, it is not clear how this 




Correction of enthalpy of bio-5’-AMP binding for holoBirA 
dimerization 
Titration data indicate that all variants except for G196A have different 
energetic contributions to bio-5’-AMP binding than wild type. Variant G196A is 
unique in that it is the only protein with a more favorable dimerization free energy 
than wild type BirA. Because of the linkage between corepressor binding and 
dimerization, dimer assembly is a complicating factor in the analysis of ITC-derived 
binding enthalpies. Moreover, because of the large positive enthalpy of dimerization, 
41±3 kcal/mol31, low quantities of dimer formation contributes significantly to the 
measured heats. For this reason, despite designing the experiments to minimize this 
effect, a correction for the heat of dimerization was performed on the measured 
enthalpies of bio-5-AMP binding. 
The fraction of BirA dimer, 𝜒𝐷𝐼𝑀, was calculated for each variant at the total 
protein concentration, Ptot, at the end of each titration. This calculation was performed 
using the following expression and the equilibrium dimerization constants, KA,DIM, 
previously measured at 20°C20:  
𝜒𝐷𝐼𝑀 = 1 − 𝜒𝑚𝑜𝑛𝑜𝑚𝑒𝑟 = 1 −











Figure 4.1: Structural comparison of G142A BirA to wild type BirA. 
Structural features of the dimerization surface are compared between wt apo (pdb entry 
1BIA), wt holo (2EWN), and G142A (4WF2) BirA. Folding of the 193-197 loop (pink) is 
dependent on the alpha helical extension observed in residues 143-146 (dark green). It 





At the protein concentrations used, at least 10% dimer was present in wild type BirA 
and variants G196A, K283A, and E140A BirA (Figure 4.1) 
Therefore, the experimental contribution from BirA dimerization, qdim, to the 
measured heat of injection, qinj, is: 
𝑞𝑖𝑛𝑗 = 𝑞𝑑𝑖𝑚 + 𝑞𝑏𝑖𝑜−5′−𝐴𝑀𝑃 
where qbio-5’-AMP is the desired parameter, heat due to ligand binding. This value was 
calculated using the equation: 
𝑞𝑑𝑖𝑚 = ∆𝐻°𝑑𝑖𝑚 ∙ [𝐵𝑖𝑟𝐴2] 
= ∆𝐻°𝑑𝑖𝑚 ([ℎ𝑜𝑙𝑜𝐵𝑖𝑟𝐴] −
−1 + √1 + 8𝐾𝐴,𝐷𝐼𝑀[ℎ𝑜𝑙𝑜𝐵𝑖𝑟𝐴]
4𝐾𝐴,𝐷𝐼𝑀
) 
 using the enthlapy of BirA dimerization, ∆𝐻°𝑑𝑖𝑚, obtained for wild type BirA. The 
incremental change in ligand-bound protein concentration, [holoBirA], was equal to 
the incremental ligand concentration calculated by the Microcal VP-ITC software due 
to stoichiometric binding conditions. The dimerization constants for each variant, 
KA,dim, are known at 20°C
20, and were determined at the remaining temperatures using 
the wild-type BirA temperature dependence31. To determine the enthalpy of binding, 
the measured heat due to bio-5’-AMP binding is normalized to the moles of injectant 





Where Cinj is the concentration of the ligand solution and Vinj is the volume of each 
injection.  
By performing this correction, it is assumed that the enthalpy of dimerization 




The basis for this assumption is that measurements of the effect of replacing H2O 
with D2O are consistent with solvent release serving as the molecular origin of this 
large positive enthalpy34. Because similar isotope effects are observed on the 
dimerization free energies of T195A and V219A BirA, it seems reasonable to assume 
∆HDIM does not differ dramatically from that of wild type despite their free energy 
penalties to dimerization.  
Correcting for dimerization reveals binding enthalpies for wild type and 
G196A BirA now more consistent with the other variants (Figure 4.2). The entropy 
of binding is revealed to be unfavorable for wild type, G196A, and K283A BirA. This 
enthalpy-entropy compensation phenomenon, in which large variations in 
thermodynamic parameters lead to little or no change in ∆G°binding has been seen in 
other systems in which small perturbations are made to interacting species35,36. 
In G142A BirA, the loss of free energy stems from a less favorable enthalpy 
by 2±1 kcal/mol compared to wild type and a more negative, but within error, -T∆S° 
by 1±1 kcal/mol. A less favorable binding enthalpy is also observed in T195A, 
D197A, I280A, and G281A BirA, each of which dimerizes at least 1 kcal/mol less 






Table 4.1:Fraction of BirA dimer present in ITC titrations 
 
Fraction dimers above were calculated using the expression: 
𝜒𝐷𝐼𝑀 = 1 − 𝜒𝑚𝑜𝑛𝑜𝑚𝑒𝑟 = 1 −
−1 + √1 + 8𝐾𝐴,𝐷𝐼𝑀𝑃𝑡𝑜𝑡
4𝐾𝐴,𝐷𝐼𝑀𝑃𝑡𝑜𝑡
 
at 1.8uM BirA, the average concentration at the end of the TAPS measurements performed. 
The Dimerization parameters used were obtained from Adikaram 201220 
  
 
BirA variant Fraction Dimer  













optimize electrostatic interactions on the dimerization surface upon allosteric 
activation. Although the observed changes in bio-5’-AMP binding enthalpy could 
also reflect structural changes on the ligand binding surface, all hydrogen bonding 
interactions to the ligand remain present in G142ABirA and the ligand binding 
affinity remains unchanged despite the enthalpic penalty in the remaining variants 
(Figure 4.2,Table 4.2). For this reason it appears the loss of dimerization free energy 
stems from disrupting intramolecular interactions on the dimerization surface of the 
monomer. 
∆C°p,bio-5’-AMP values directly correlate to BirA dimerization 
All BirA variants show a more negative heat capacity change of bio-5’-AMP binding 
than wild type and G196A BirA. Additionally, no correlation is observed between 
heat capacity change and dimerization free energy of each variant (Figure 4.5A) 
.However, because the heat capacity changes were derived from the enthalpies of bio-
5’-AMP binding, the heat of BirA dimerization is also a consideration. Therefore, the 
correction was performed as above for the binding enthalpies at each temperature 
obtained by ITC TAPS titrations. Due to the temperature dependence of BirA 
dimerization31, the KD,DIM  at each temperature was calculated from the variant’s 
dimerization free energy at 20°C. This was performed by using the Van’t Hoff 
equation, assuming the BirA temperature dependence of dimerization was conserved 
upon alanine mutagenesis. The corrected heat capacity changes ( 
Figure 4.3,Table 4.3) remain negative but are higher in magnitude compared to the 
non-corrected values. It is revealed that wild type, K283A, and G196A BirA have the 




Table 4.2: Corrected thermodynamic parameters of bio-5’-AMP binding to dimerization 
surface variants 
 
All measurements were performed in 10mM Tris (pH 7.5), 200mM KCl, 2.5mM MgCl2 at 
20°C. Each value represents the average of at least two independent ITC titrations. Errors 
given are 68% confidence intervals propagated from the nonlinear least squares analysis. 
a Obtained from nonlinear least squares analysis of the titration data to a single site binding 
model in Origin 7.0. 
b Measured using direct TAPS titrations, corrected for BirA homodimerization as described in 
discussion 





















































Figure 4.2: Corrected thermodynamic contributions to bio-5’-AMP binding. 
The enthalpic (red) and entropic (blue) components of the free energy of bio-5’AMP binding 
for each BirA species studied following correction for BirA homodimerization. Errors bars 
shown are the propagated 68% confidence intervals.   
 




















 -14.1±0.5 -15±1 1±1 1.06±0.02 
E140A 7(±3)x10
-11
 -13.6±0.2 -13.7±0.5 0.0±0.5 0.90±0.01 
G142A 8 (±1)x10
-9
 -10.85±0.09 -13.2±0.1 2.3±0.2 1.010±0.01 
P143A 8(±2)x10
-11
 -13.5±0.2 -12.9±0.2 -0.6±0.3 0.96±0.01 
T195A 1.0(±0.4)x10
-10
 -13.4±0.2 -12.9±0.1 -0.5±0.2 0.88±0.01 
G196A 2(±3)x10
-11
 -14.2±0.8 -16±1 2±2 1.09±0.03 
D197A 9(±3)x10
-11
 -13.5±0.2 -12.2±0.2 -1.3±0.3 1.21±0.02 
I280A 9(±2)x10
-11
 -13.5±0.1 -12.6±0.1 -0.9±0.2 1.06±0.01 
G281A 8(±3)x10
-11
 -13.6±0.2 -13.1±0.3 -0.5±0.4 0.89±0.01 
K283A 9(±2)x10
-11






Figure 4.3: Effects of the correction for wild type BirA homodimerization on the heat 
capacity change of bio-5’-AMP binding.  
Data shown are enthalpy of bio-5’-AMP binding as determined by TAPS titrations at 10-25C 







Table 4.3: Corrected heat capacity changes for Bio-5’-AMP binding to BirA variants 
 
Heat capacity changes of bio-5’-AMP binding to the BirA dimerization surface variants 
corrected for the presence of BirA dimerization. 
aCalculated from linear regression of the temperature dependence of the corrected ∆H°bio-5‘-
AMP (Figure 3.6). Uncertainty given in ∆C°p is the 68% confidence interval from linear 
regression. 
b Change in ∆C°p from wild type, ∆∆C°p Calculated by the expression ∆C°p,variant-∆C°p,wt. 
















































Figure 4.4: Comparison of corrected heat capacity change measurements. 
The ∆C°p of bio-5’-AMP binding before correction (dark) corrected for the enthalpy of BirA 
















E140A -0.58±0.05 0.17±0.08 
G142A -0.31±0.01 0.44±0.06 
P143A -0.49±0.02 0.26±0.06 
T195A -0.43±0.02 0.32±0.06 
G196A -0.68±0.06 0.07±0.08 
D197A -0.37±0.01 0.38±0.06 
I280A -0.31±0.01 0.44±0.06 
G281A -0.38±0.01 0.37±0.06 































































































Figure 4.5.Functional correlations of the heat capacity change of bio-5’-AMP binding 
The change in heat capacity is illustrated in relation to both dimerization and bio-5’-AMP 
binding free energies for each BirA variant. Error bars represent the 68% confidence 
intervals of the respective thermodynamic parameters. A) Correlation plot of the heat 
capacities as measured. B) Correlation plot using the corrected heat capacity values. BirA 






capacity changes (Figure 4.4). This correction reveals a striking positive correlation 
between dimerization free energy and ∆∆C°p (Figure 4.5B).Excluding variants 
G142A and I280A, which are not well-described by a linear function, the remaining 
variants assume a linear relationship with a slope of 4.5 kcal/mol of dimerization free 
energy per kcal/mol increase in ∆C°p. 
Interpretations of ΔC°p have often focused on correlations established to 
changes in solvent accessible surface area37. However, this interpretation has not been 
demonstrated to be consistent in all systems. Changes in hydrogen bonding and 
electrostatic interactions have also been demonstrated to give rise to negative heat 
capacity changes38,39.  
An alternative interpretation given by Alan Cooper is that negative heat 
capacity changes may be an expected consequence for the disorder to order 
transitions occurring in BirA. He demonstrates this by deriving ∆C°p using a 
statistical thermodynamic model in which a network of interacting subunits undergo a 
cooperative transition40. Following this interpretation, it would be expected that the 
heat capacity change would be more positive in variants that do not undergo as 
significant of a disorder-to-order transition. Using this interpretation, the most 
negative heat capacities are consistent with the full disorder-to-order transition 
observed in wild type BirA including G196A, E140A and K283A. The remaining 
BirA variants have significantly more positive heat capacity changes consistent with 
perturbations of loop folding. Because there are no functional effects observed to 
ligand binding, these perturbations to loop folding can be tied to the 193-197 disorder 




the G142A structure that disorder-to-order loop folding is coupled to allosteric 
activation of BirA by demonstrating a direct correlation between dimerization free 
energy and heat capacity change, a parameter associated with both protein folding 
and disorder-order transitions. 
Formation of intramolecular interactions is observed upon allosteric 
activation 
Analysis of the wild type apo and holoBirA structures reveals multiple 
intramolecular interactions occurring upon helical extension of residues 143-146 and 
folding of the 193-197 loop (Table 4.4). Disruption of these intramolecular 
interactions formed upon allosteric activation by alanine substitution has moderate 
effects on the heat capacity change of bio-5’-AMP binding (Figure 4.4). Due to the 
correlation between ∆∆G°DIM and ∆∆C°p these variants also have more positive 
dimerization free energies consistent with perturbed loop folding. However, there are 
no obvious intramolecular interactions that exist in wild type holoBirA which would 
be perturbed in I280A BirA, despite its deficit to free energy of dimerization. Because 
of the pronounced functional effect observed for these variants and their lack of 
correlation with heat capacity change, the effects that are observed on the 











K194-D197 Salt Bridge 3.4 
K194b-D197b Hydrogen bond 3.0 
K194b-A198b Hydrogen bond 3.4 
P143b-A146b Hydrogen bond 2.9 
R119-D282 Salt Bridge 4.1 
R119-E313 Salt Bridge 3.7 
R118-D176 Salt Bridge 3.0 
R118-V189b Hydrogen bond 3.5 
Interactions above are those observed are on the dimerization surface (top) and those at 
conserved R118 and R119 residues in the BBL(bottom). These were determined from 






Chapter 5 : Conclusions and Future Directions 
The results indicate a model for allosteric activation of the BirA monomer in 
which bio-5’-AMP binding and folding of the ABL induce an alpha helical extension 
of residues 143-146. This helical extension optimizes the dimerization surface for 
formation of intramolecular interactions and subsequent folding of the 193-197 loop. 
Proper folding and arrangement of these regions occur in activation of the molecule 
for dimerization. However, the mechanism by which the allosteric signal is 
communicated to residues 143-146 is not clear from this study.  
Because there are no other observable structural consequences in G142A 
BirA, investigation of this mechanism must proceed by either garnering further 
structural data of alanine mutations that perturb the alpha helical transition, or by non-
structural methods such as molecular dynamics (MD) simulations that investigate the 
changes of protein dynamics upon BirA activation. Evidence from prior H/D 
exchange mass spectra41 indicate a global dampening of BirA dynamics upon 
allosteric activation, suggesting that investigation of the role of protein motions may 
be required for full understanding the molecular mechanism of BirA allostery. 
Analysis of correlated motions and residue-residue contacts42 using molecular 
dynamics simulations could provide insight and, more importantly, testable 
hypotheses to further investigate how the α-helical extension of the 143-146 residues 





Chapter 6 :Appendicies 
Appendix 1: Discrepancy between ∆HTAPS and ∆Hdisplacement  of bio-5’-
AMP binding 
The purpose of this appendix is to address a discrepancy that is observed 
when measuring the enthalpy of bio-5’-AMP binding using two different ITC titration 
methods. The enthalpies measured by the displacement technique are 1-3 kcal/mol 
more negative than those measured directly by TAPS titrations. The P143A variant 
has the largest deviation, 3.1±.1 kcal/mol. Displacement titrations for the remaining 
proteins also yielded more favorable enthalpies by 1-2.5 kcal/mol except for G142A 
BirA, for which a displacement titration could not be performed (Figure 6.1). For this 
variant, no difference was observed between the direct and TAPS measurement. For 
this reason and due to the relative simplicity of the direct measurements, investigation 
into possible sources of the discrepancy was focused on the displacement method. 
However, a likely source of the more negative enthalpy of binding from displacement 
titrations was not found. Nontheless, the accuracy of the Gibbs free energies 
measured by displacement titrations and the enthalpy of bio-5’-AMP binding 
measured by TAPS titrations are strongly supported by experimental evidence. 
Possible sources of experimental discrepancy 
To attempt to discern the source of the 1-3 kcal/mol deviation observed 
between TAPS and displacement-obtained enthalpies of binding, differences in both 
experimental protocol and reagents used were examined. The enthalpies determined 

























































Figure 6.1. Discrepancy between bio-5’-AMP binding enthalpy from TAPS and 
displacement ITC measurements. 
Values of ∆∆H °Calculated by ∆∆H°=∆H°TAPS-∆H°Disp for each BirA variant. Protein and ligand 
solutions for both methods were prepared in 10mM Tris (pH=7.50 at 20°C), 200mM KCl, 






new reagents (Table 3.1Table 6.1). The deviation was reproducible using different 
reagents at a later date. Because of this, it is not believed that there is any systematic 
error due to the reagents used or the order in which experiments were performed. To 
further demonstrate the ligand was intact for these titrations, the bio-5’-AMP solution 
was analyzed by TLC (see materials and methods). The presence of contaminating 
biotin in the bio-5’-AMP reagent was a concern because of its more negative enthalpy 
of binding. However, the presence of only a single spot at the correct retention 
distance, 0.53, was indicative of no contaminating biotin in the solution.  
Additionally, systematic experimental deviations could stem from differences 
in the protocol between the two methods. Displacement titrations uniquely require the 
inclusion of saturating biotin and this presence of excess biotin represents a difference 
in the chemical environment of the bio-5’-AMP binding reaction. To determine if the 
excess biotin used affected the enthalpy of corepressor binding, displacement 
titrations were performed using both 3µM and 6µM biotin for I280A BirA. A ∆∆H° 
between methods of 1.4±0.1 and 1.6±0.1 kcal/mol, respectively, was still observed at 
both concentrations. These results indicate that the presence of excess biotin, which 
was present in each displacement titration, does not significantly affect the measured 









Table 6.1. Reproduction of displacement titration measurements 
 








Original 9(±1)x10-11 -13.5±0.1 -14.5±0.1 1.0±0.1 1.16±0.01 
Reproduction 1.0(±0.2)x10-10 -13.4±0.2 -14.4±0.1 1.0±0.2 0.97±0.01 
K283A BirA      
Original 1.1(±0.2)x10-11 -13.4±0.1 -14.8±0.1 1.4±0.1 0.87±0.1 
Reproduction 1.1(±0.4)x10-11 -13.3±0.2 -15.2±0.2 1.9±0.2 0.87±0.1 
Measured at 20°C by displacement ITC titration in 10mM Tris (pH=7.50 at 20°C), 200mM KCl, 
2.5mM MgCl2 . Each parameter represents the results from non-linear least squares 
regression of a single ITC isotherm. The uncertainty provided is the 68% confidence interval 





∆G°bio-5’-AMP measured by biotin displacement agrees with those measured 
by direct titrations. 
 Because of the presence of this discrepancy between the measured enthalpies 
of bio-5’-AMP, the accuracy of the parameters obtained from both methods were in 
question. Measurement of the Gibbs free energy and the enthalpy of bio-5’-AMP 
binding by ITC is inherently coupled, however it was possible to validate the free 
energy values obtained by direct comparison to the results of a direct titration. To 
perform this experiment, a variant was carefully chosen so that its c-value would be 
within the measureable range for both direct and biotin displacement titrations. The 
BirA variant W223A allowed for these measurements, providing c-values of ~8 and 
~300 for the displacement and direct titrations respectively (Figure 6.2). These 
measurements yielded ∆G°bio-5’-AMP of -11.7±0.2 -11.2±0.2 indicating that the Gibbs 
free energies as measured by displacement titrations well-represent those that cannot 
be determined directly(Table 6.2). In additional support of the of the Gibbs free 
energy values obtained by this method, the wild type ∆G°bio-5’-AMP (Table 3.3) is 
within 0.5 kcal/mol of that calculated from the results of previous kinetic 
measurements, -13.6±0.2 kcal/mol43. For this reason it is believed that the free 
energies obtained by biotin displacement ITC titrations are valid and therefore were 








Figure 6.2 Direct versus Displacement titration of W223A BirA.  
Data is illustrated for both direct binding(A) and displacement(B) ITC methods. Protein and 
ligand solutions were prepared in 10mM Tris (pH=7.50 at 20°C), 200mM KCl, and 2.5mM 
MgCl2. The top panel is the ITC data trace following manual baseline correction. After 
integration and normalization to the moles of injectant, the binding isotherm, bottom panel, 
is obtained. Non-linear least squares regression of each isotherm to the single-site binding 
model provides the ligand binding parameters. 
 
 
Table 6.2 Comparison of direct and displacement bio-5’-AMP binding measurements. 
 
 
All measurements were performed in 10mM Tris (pH 7.5), 200mM KCl, 2.5mM MgCl2 at 
20°C. Each value represents the average of at least two independent ITC titrations. Errors 





∆H°biotin measured directly agrees with that measured by TAPS titration. 
 Because of the discrepancy between direct and displacement ITC titrations, it 
must be determined which method most accurately provides the enthalpy of bio-5’- 
AMP binding. Ultimately, biotin displacement is an indirect measurement of both the 
enthalpy and free energy of bio-5’-AMP binding. The parameters determined from 
this competitive assay have a lower signal-to-noise and rely on accurate measurement 
of the enthalpy and association constant of biotin, both of which have an associated 
error. Due to the comparative complexity of the displacement titrations, it is believed 
that the binding enthalpy obtained from TAPS measurements provides a more 
accurate value. To demonstrate this, the enthalpies of biotin binding, which have also 
been characterized by full-direct titrations in this study, were reproduced for three 
dimerization surface variants using the TAPS method (Figure 6.3). No deviation was 
observed for both K283A BirA and E140A BirA. P143A BirA was also examined in 
this way and a small deviation, ∆∆H° = 0.5±0.3 kcal/mol, was measured between 
TAPS and direct titrations (Figure 6.4, Table 6.3). However, this difference is much 
smaller than that measured between TAPS and displacement methods, 
3.1±0.1kcal/mol. These results demonstrate reproducibility and consistency of the 
enthalpies determined from TAPS measurements compared to those determined from 
direct titrations. Therefore, the molar enthalpies of bio-5’-AMP binding determined 
from displacement titrations were not analyzed in this study and instead only those 
values obtained from TAPS titrations were considered. Ultimately, these enthalpies 
were used to calculate the entropic components (-T∆S) and heat capacity changes of 





Figure 6.3 Biotin TAPS titration of P143A BirA. 
Both protein and ligand solutions were prepared in 10mM Tris (pH=7.50 at 20°C), 200mM 
KCl, 2.5mM MgCl2. The top panel is the ITC data trace following manual baseline correction. 
After integration and normalization to the moles of injectant, the binding isotherm, bottom 
panel, is obtained. The difference between the molar heat before and after protein 






Figure 6.4 Difference of bio-5’-AMP binding enthalpy between direct and TAPS ITC 
measurements. 
Values of ∆∆H °Calculated by ∆∆H°=∆H°TAPS-∆H°Direct for each BirA dimerization surface 
variant. Protein and ligand solutions for both methods were prepared in 10mM Tris 
(pH=7.50 at 20°C), 200mM KCl, 2.5mM MgCl2.Errors reported are the propagated 68% 
confidence interval of the individual enthalpy measurements. 
 







P143A -20.2±0.4 0.5±0.4 
E140A -20.1±0.5 0.0±0.5 
K283A -20.6±0.4 0.2±0.5 
Biotin TAPS titrations performed in 10mM Tris (pH=7.50 at 20°C), 200mM KCl, 2.5mM MgCl2 
A large protein concentration, 5µM, was used to assure stoichiometric biotin binding. 
Enthalpies reported from the average of two TAPS titratrations containing five pre-
saturation injections each. Errors reported are propagated 68% confidence intervals. 
∆∆H°biotin calculated using the equation ∆∆H°biotin=ΔH°TAPS-ΔH°Direct where ΔH°Direct values are 





Appendix 2:Considerations in the Design of ITC experiments 
 All ITC titrations in this study were designed with several experimental 
factors in mind which are detailed below. Particularly, careful consideration was 
given to the Wiseman ‘c’ value44 and the concentration and size of each ligand 
injection.  
Wiseman’s c-value for the design of ITC titrations 
The ‘c’ parameter, where c=KA∙[P]∙n, is a function of the association constant, 
KA, total protein concentration, [P], and binding stoichiometry, n, for a single-site 
binding interaction. Of these parameters, only the protein concentration is modifiable 
in the design of a simple binding ITC experiment. This choice is limited on the upper 
and lower bounds by the quantity of protein able to be purified and the minimum 
protein concentration required to achieve a measureable heat of interaction upon 
injection (ideally ~5µcal or more, but as low as ~1µcal can be analyzed with quality 
data). In this study, increasing the protein concentration was also limited by the 
presence of a coupled homodimerization reaction. Nonetheless, the c-value was 
maintained within the recommended range of about 5-500, because titration data with 
a c-value outside this range provide a binding curve with less information about the 
binding process The titration curve asymptotically approaches a step-function 
(Figure 6.5)., which contains no information regarding the association constant of 
binding, at large-c-values (stoichiometric binding). However, both the experimental 





Figure 6.5 Simulated influence of c-value on single-site ITC binding curve. 
Heat of injection from c=0.01 to c=1x104 were simulated using the parameters: ΔH=-
6kcal/mol, KD=2x10-8M, and n=1. The protein concentration was varied in each case to 




conditions, which is the basis of total association at partial saturation (TAPS) 
measurements. Values obtained from small c-value binding curves can be misleading, 
because they generally do not reach saturation over the course of titration. Therefore, 
these measurements provide only a small portion of the full binding curve from which 
an accurate stoichiometry and enthalpy of binding cannot be determined. The 
association constant of binding is theoretically accessible at a low c-value (as long as 
the heats of binding upon injection are measureable), but precautions must be taken to 
assure full protein saturation45. C-values utilized were approximately 100 and 
100,000 for the direct biotin binding and bio-5’-AMP TAPS measurements, 
respectively.  
Although the c-value is a parameter derived from the single-site binding 
equation, it can also be used to describe the biotin displacement titrations in this 
study. This is because the competition titrations performed were all using saturating 
concentrations of the competing ligand, which results in a pseudo-single-site binding 
curve for which the apparent association constant is a function of the KA of both 





Therefore the c-value of a displacement titration is calculated using the apparent 
association constant. Decoupling of the actual binding constant from the c-value is 
what permits competitive binding assays to measure association constants 
significantly tighter than those accessible by only direct binding. A typical c-value 




Ligand concentration and injection scheme 
Another important consideration in the design of ITC titrations is determining 
the quantity of ligand to be injected and the number of injections over which this will 
occur. The quantity of ligand injected should be large enough that the protein is 
ultimately saturated with ligand at the end of the titration. Unless the c-value of the 
titration is particularly low, a final ligand/protein ratio of 2.2-2.5 is acceptable for 
complete saturation. This translates to a ligand concentration about 10-fold larger in 
the injection syringe than the protein concentration present in the sample cell. 
Titration with a quantity of ligand much greater than this will than this will, because 
the protein is saturated after only several injections, only provide a fraction of the 
binding curve. Determination of the stoichiometry and enthalpy of binding will then 
be difficult (Figure 6.6). 
In the determination of an injection scheme, or what quantity and size of 
ligand injections to use, the use of a simulation program is highly recommended. To 
maximize the amount of data available for nonlinear-least squares regression, a full, 
symmetrical binding curve, with several injections before and after protein saturation, 
should be used (see Figures 3.1, 3.3 for examples). For this study, the titration 
parameters were optimized by simulating ITC titrations using a spreadsheet provided 
by T. Biswas and O.V. Tsodikov29 (Figure 6.7). Injection volumes were chosen so 
that multiple injections (3-4) were present on the saturation and pre-saturation 







Figure 6.6 Example ITC titration using excess ligand. 
Too much ligand was used, resulting in early saturation of the protein in the course of this 
direct biotin titration.  
  


















































Figure 6.7 Simulation of a direct biotin binding titration. 
This Microsoft-Excel-based tool allows simulation of single-site and pseudo single-site 
binding titrations. The user provides the experimental parameters (green, yellow, or grey 
cells) and the heat of injection is calculated for an indicated number of injections u sing the 




Appendix 3: Expression and purification of BirA variants 
BirA alanine variants used in this study were expressed and purified as 
previously described18,20, except for variants E140A and K283A which were prepared 
as follows. Approximately 50ng of pBtac2 BirA-(His6) plasmid
25 DNA containing the 
appropriate variant coding sequence was transformed at 1500V into 50μL of JM109 
electrocompetent cells. Immediately after electroporation (BTX-ECM399), cells were 
suspended in 1mL of cold SOC media and incubated at 37°C for an hour. Both 5μL 
and 20μL of transformed cells were spread evenly onto separate LB/AMP agar plates 
and subsequently grown at 37°C overnight. The pBtac2 BirA-(His6) plasmid contains 
the β-lactamase gene that confers ampicillin resistance. Inclusion of ampicillin 
(100μg/mL) in both LB agar and the liquid media allowed for selection of only 
transformed colonies.  
Following transformation, 2-3 well-separated colonies were inoculated into 
5mL of LB/AMP and shaken overnight at 37°C. Prior to their usage for the large-
scale preparation of BirA, the induction of each cell line was assessed by a small-
scale induction trial. To perform this trial, half of each overnight culture (2.5mL) was 
inoculated into 20mL of sterile LB/AMP. The remaining 2.5mL of culture was stored 
at 4°C until needed. After inoculation, the 20mL culture was incubated at 30°C until 
the OD600 reached 0.6. At this point, 0.5mL aliquots of each culture were removed as 
a pre-induction sample. These samples were pelleted by centrifugation for 5 minutes 
at 10,000rpm and stored at -20°C for subsequent SDS-PAGE analysis. Because the 
pBtac2 BirA-(His6) plasmid is transcriptionally controlled by the tac promoter, 




concentration. After 4 hours of 200 rpm shaking at 30°C, the OD600 of each culture 
was recorded and a second 0.5mL aliquot was removed from each induction trial for 
analysis. These aliquots were similarly pelleted as above, and all cell-pellets were 
decanted then dissolved in a volume, 
 𝑂𝐷600
12
 mL, of Laemmeli sample buffer26 (LSB) 
normalized to the OD600 of the culture at the time it was removed. This process 
confers a constant protein concentration to all SDS-PAGE samples so they may be 
qualitatively compared. The culture that demonstrated the highest induction of BirA, 
and of no other proteins, was chosen for large-scale protein preparation. The 
remaining 2.5mL of the chosen cell line was inoculated into 300mL of LB/AMP and 
shaken (200rpm) overnight at 37°C as a starter culture for protein expression. 
The 300mL overnight culture was evenly divided into two 4L Erlenmeyer 
flasks, each containing 2L of sterile LB/AMP media.  Cells were grown at the 
induction temperature, 30°C, with shaking at 175rpm until the OD600 reached 
approximately 0.8. At this point, a 0.5mL aliquot was removed and pelleted as above 
for SDS-PAGE analysis. Overexpression was induced by adding IPTG to a final 
concentration of 1mM. After starting induction, the cultures were shaken for an 
additional 4 hours in identical conditions. Once induction was complete, the cell 
solutions were cooled on ice to 4°C. Care was taken to keep the cell solutions, cell 
pellet, and cell lysate at this temperature throughout the preparation steps to preserve 
BirA integrity. A 1L centrifugation bottle (Hitachi) was weighed prior to pelleting the 
cells, so that total cell mass could later be determined. The cell suspension was 
pelleted by centrifugation 2L at a time at 4500 rpm for 20 minutes at 4°C. This 




suspension evenly (about 500mL x4 bottles) and carefully balancing (±0.5g) the 
suspension between bottles placed oppositely into the F8S-4x1000y rotor. The cell 
pellets were then washed by suspension in excess lysis buffer (50mM NaH2PO4, 
300mM NaCl, 10mM Imidazole, 5% glycerol, 100μM DTT, pH 8), and combined 
into a single pre-weighed centrifuge bottle. After a second centrifugation at 4500rpm 
for 20 minutes, the lysis buffer was carefully decanted and the mass of the remaining 
cell pellet weighed on an analytical balance. Cells were gently suspended by Pasteur 
or transfer pipet into 5mL of lysis buffer per gram of cell pellet. 
For lysis, the cells were transferred to the smallest-allowable, pre-chilled 
metal lysis cup. The sample was sonicated (Branson Sonifier 450) for 2-minute 
intervals in lysis buffer at sonifier output and duty cycle of 60% to minimize sample 
heating. The cell lysate was maintained below 10°C during lysis using a salt/ice bath. 
To inhibit serine protease activity, 0.01% of the total cell lysate volume of 100mM 
PMSF was introduced prior to each sonication interval. Lysis was considered 
complete when the OD600 of a cell lysate sample (diluted 1:100 in lysis buffer) was 
<10% of the initial value. Centrifugation at 5.4 x g for 30min at 4°C was performed 
to remove cell debris. Nucleic acids were precipitated from the decanted supernatant 
by adding PEI (pH=7.5) to a final concentration of .1% (v/v) at 4°C for at least 15 
minutes.  Another centrifugation step at 5.4 x g for 30min at 4°C pelleted the 
resulting PEI precipitate. Both cell debris and PEI pellet were suspended into lysis 
buffer in a volume equal to the respective supernatant. Aliquots (0.5mL) of both 
precipitate suspensions and both supernatants were removed for SDS-PAGE analysis. 




presence in the PEI supernatant was confirmed by a 12.5% SDS-PAGE gel. The 
sample from each expression and purification step was diluted 1:1 into LSB, mixed 
well and heated at 90°C prior to loading 10uL onto a 12.5% acrylamide SDS-PAGE 
gel, prepared according to the Laemmli discontinuous gel system26. 
Purification of BirA variants from the resulting crude lysate was performed by 
several chromatography steps using an ÄKTA Prime (GE) liquid chromatography 
system. All resins were packed in a 1.5cm diameter Bio-Rad econo-column. Between 
4 and 5cm (about 7mL) of resin was packed in each 15cm column. Each resin used 
for purification, except the HA Ultrogel, was regenerated before purification using a 
resin-specific protocol (see resin regeneration). All resins were equilibrated with at 
least 10 column volumes of resin-specific starting buffer directly before use. Because 
the variants have a C-terminal His6-tag, a nickel affinity column (Ni-NTA agarose, 
Qiagen) was the first BirA purification step. After dialysis of the PEI supernatant into 
fresh lysis buffer (at least 2 L, twice), the protein solution (about 150mL) was loaded 
at 1mL/min onto 7mL of Ni-NTA resin. BirA was eluted in 5mL fractions using an 
imidazole step gradient starting from 20mM, and proceeding to 50mM, 100mM and 
finally 250mM. This gradient was performed by eluting with 0%, 13%, 34%, and 
100%, respectively, of elution buffer in Ni-NTA starting buffer (50mM NaH2PO4, 
300mM NaCl, 20mM imidazole, 100μM DTT, 5% glycerol, pH=8) at 0.5mL/min. 
Each elution step was begun only after the A280 was constant for at least 5 minutes. 
The E140A variant and K283 variant eluted at 50mM and 100mM imidazole, 
respectively. Following SDS-PAGE (12.5%) analysis of each fraction (1:1 in LSB), 




sample were pooled and exchanged twice by dialysis against 2L (about 25:1 
buffer:dialysate) of SP-sepharose starting buffer. 
The second purification step for both E140A and K283A was chromatography 
on SP-sepharose (GE-Healthcare) cation exchange resin. After equilibration of 7mL 
of resin with SP-sepharose starting buffer (50mM Tris pH 7.5 at 4oC, 50mM KCl, 
100mM DTT, 5% glycerol), the protein solution was loaded at 0.9mL/min. The BirA 
variants were eluted using a linear KCl gradient from 0.05M-0.8M (0-100% elution 
buffer) over 110mL. BirA elution was observed at about 0.3M KCl (33% elution 
buffer) for both variants.   
Additional purification of the E140A BirA variant was performed using a Q-
sepharose (GE-Healthcare) anion exchange resin using the same loading, elution, and 
regeneration steps as the SP resin, except that the resin was stored in only 20% 
ethanol. BirA is eluted at a low salt concentration from the Q-sepharose column, for 
some mutants this occurs in the wash step. Consequently, 2mL fractions were taken 
during loading and starting buffer wash in addition to the elution gradient.  
Following two 500mL (33:1) dialysis steps of the 15mL protein solution into 
HA starting buffer, further purification of the E140A BirA variant was achieved using 
a hydroxyapatite Ultrogel (Pall) mixed-mode resin. The protein solution was loaded 
at 0.5mL/min onto 5mL of HA resin equilibrated in starting buffer. The protein was 
eluted at 0.5mL/min using a linear 0.05M-0.5M phosphate gradient, or 0-100% HA 
elution buffer (50mM sodium phosphate pH=6.5, 100μM DTT, 5% glycerol) in HA 
starting buffer over 100mL. Each 3mL fraction containing pure E140A BirA, 




of storage buffer (200mM KCl, 50mM Tris, 100μM DTT, 5% glycerol, pH=7.5 at 
4°C). 
All purified variants were dialyzed twice in at least 1:30 of protein:storage 
buffer and filtered using a 0.22um PVDF syringe filter pre-rinsed in storage buffer. 
The final protein solutions were mixed carefully to achieve homogeneity and 
aliquoted into 1mL fractions for storage at -80°C. Coomassie brilliant blue stains of 
samples subjected to 12.5% SDS-PAGE indicated that all BirA variants were ≥95% 
pure. Stoichiometric bio-5’-AMP binding titrations, monitored by fluorescence 
spectroscopy, indicate ≥85% ligand binding activity. BirA concentration was 
determined by the average of three measurements of the absorbance at 280nm using 
the molar extinction coefficient, 47510 M-1cm-1, calculated from the protein 
sequence27. Each measurement of concentration was a different BirA dilution 
prepared gravimetrically in storage buffer to obtain a range of A280 between 0.2 and 
0.8. 
Preparation and regeneration of FPLC chromatography resins 
After use, each resin was regenerated as described below. Additionally, all 
resins that had been previously used were regenerated prior to protein purification. To 
avoid cross-contamination between protein solutions, a single resin aliquot was used 
to prepare only one specific BirA variant. In contrast to the other resins, the 
hydroxyapatite (HA) Ultrogel (PALL) was only regenerated after use since it was 
newly obtained. All resins were cleaned at 4°C by gravity-flow of a series of reagents. 




Regeneration and storage of the Ni-NTA resin following purification was 
performed with slight modification from the manufacturer’s recommendation 
(QIAGEN). First 1 column volume (c.v.) of Ni-NTA elution buffer (50mM sodium 
phosphate pH=8, 300mM NaCl, 250mM imidazole, 100μM DTT, 5% glycerol,) 
followed by 2 c.v. of Ni-NTA regeneration buffer (6M guanidinium hydrochloride, 
0.2M acetic acid) were flowed through the resin. It was then equilibrated with 5 c.v. 
of MQH2O followed by 3 c.v. of 2% sodium dodecyl sulfate (SDS) in water. 
Subsequently, 1 c.v. of first 25%, then 50%, and finally 75% ethanol was used. The 
column was then washed with 5 c.v. of 95% ethanol, then again with 1 c.v. of 75%, 
50%, and finally 25% ethanol.  After a 1 c.v. rinse with MQH2O, the column was 
equilibrated in 5 c.v. of 100mM ethylenediaminetetraacetic acid (EDTA). This step 
removes chelated nickel (II), so the resin should lose its blue color.  Following a 5 
c.v. MQH2O wash to remove any EDTA present, the nickel is restored by rinsing the 
resin with 2 c.v. of 100mM NiSO4 in water. A 2 c.v. regeneration buffer rinse was 
used afterwards to remove excess nickel (II). If significant color does not remain, new 
resin is required. The resin is then equilibrated in 5 c.v. lysis buffer (50mM NaH2PO4, 
300mM NaCl, 10mM Imidazole, 5% glycerol, 100μM dithiothreitol (DTT), pH 8), at 
which point it was used for protein purification. For storage after regeneration, the 
resin was equilibrated in 5 c.v. of 30% ethanol at 4°C. 
Regeneration of the SP-sepharose column was performed by gravity-flow of 2 
c.v. of 2M NaCl, followed by 10 c.v. of 1M NaOH, and finally 8 c.v. of 70% ethanol. 
The regenerated resin was equilibrated with 5 c.v. of SP-sepharose starting buffer 




purification, or in 20% ethanol, 0.2M sodium acetate for storage at 4°C. The Q-
sepharose column was regenerated and stored identically, except that it was stored 
without sodium acetate.  
The HA resin was regenerated by gravity flow of 4 c.v. of 500mM sodium 
phosphate pH=6.8, followed by 4 c.v. of 0.1M NaOH, and another 4 c.v. of 500mM 
sodium phosphate pH=6.8. Prior to storage, the resin was equilibrated in 5 c.v. of HA 
starting buffer (50mM sodium phosphate pH=6.5, 100μM DTT, 5% glycerol) 
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